Yehuda Handelsman

10PUBLICATIONS
38CO-AUTHORS
Exercise physiologyCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPeople with disabilityCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 31, 2026
Fat, muscle, and anti-obesity medications in cardiovascular disease prevention.

Muhammad Shahzeb Khan, Muhammad Hamza Dawood, Yehuda Handelsman

|Jun 23, 2025
Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone Treatment.

Ralph A DeFronzo, Vivian Fonseca, Vanita R Aroda

|Jun 22, 2025
Cardiovascular Outcomes and Efficacy of the PCSK9 Inhibitor Evolocumab in Individuals With Type 1 Diabetes: Insights From the FOURIER Trial.

Yu Mi Kang, Robert P Giugliano, Xinhui Ran

|Apr 18, 2025
Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes.

John B Buse, Steven E Kahn, Vanita R Aroda

|Dec 20, 2023
Cardio-renal-metabolic disease in primary care setting.

Mahmoud Ibrahim, Ebtesam M Ba-Essa, Jason Baker

|Oct 29, 2020
Cardiovascular Outcomes and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Current Data and Future Prospects.

Daniel A Duprez, Yehuda Handelsman, Michael Koren

Pageof 2

Frequent Collaborators

3 joint publications

Julio Rosenstock

3 joint publications

Guillermo Umpierrez

2 joint publications

Ralph A DeFronzo

2 joint publications

Stefano Del Prato